TN HB1737 | 2023-2024 | 113th General Assembly
Status
Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on January 9 2024 - 25% progression, died in chamber
Action: 2024-01-11 - Assigned to s/c Insurance Subcommittee
Text: Latest bill text (Draft #1) [PDF]
Status: Introduced on January 9 2024 - 25% progression, died in chamber
Action: 2024-01-11 - Assigned to s/c Insurance Subcommittee
Text: Latest bill text (Draft #1) [PDF]
Summary
As introduced, caps the total amount that a health insurance carrier can require a covered patient with diabetes to pay for a 30-day supply of insulin at no more than $35; caps the total price that a person who supplies prescription insulin drugs into or within this state for use by a patient with diabetes can charge for a 30-day supply of insulin at no more than $35. - Amends TCA Title 8; Title 53; Title 56, Chapter 7; Title 63 and Title 71, Chapter 5.
Title
AN ACT to amend Tennessee Code Annotated, Title 8; Title 53; Title 56, Chapter 7; Title 63 and Title 71, Chapter 5, relative to insulin.
Sponsors
History
Date | Chamber | Action |
---|---|---|
2024-01-11 | House | Assigned to s/c Insurance Subcommittee |
2024-01-11 | House | P2C, ref. to Insurance Committee |
2024-01-10 | House | Intro., P1C. |
2024-01-09 | House | Filed for introduction |
Same As/Similar To
SB1683 (Crossfiled) 2024-02-20 - Failed in Senate Commerce and Labor Committee - no second